Increase your chance of conceiving through these tests
The best surrogate marker for oocyte (human egg) quality is age. As time passes, oocytes (human eggs) decrease in both quantity and quality . The number of oocytes peaks when the female fetus develops 6 to 7 million oocytes, which falls to 1 to 2 million at birth, 3 to 5 lakh at the start of puberty , and a mere 1,000 when menopause begins.
These are some interesting facts most women are unaware of. After the age of 30 years there is a gradual decline in female fertility. Hence making women aware of the egg reserve helps clinicians advise women with low ovarian reserve to know that their window of opportunity to conceive may be narrow and encourage them to conceive sooner than later. However, since these levels differ for each woman, ovarian reserve testing is designed to assess the number and quality of the remaining oocytes to estimate an individual's potential of conception. There are the three most widely used tests: The first, basal follicle-stimulating hormone (FSH) plus estradiol, are the hor mones naturally present in women.These are measured by performing a blood test.Although basal FSH commonly is used to assess ovarian reserve, high values (greater than 10-20 inter national unitsL) are asso ciated with diminishing ovarian reserve, and show poor response to ovarian stimulation. The second screening test measures antimullerian hormone levels. This hormone decrease with age, as the number of ovarian follicles drops, and signals oocyte depletion.
Antimullerian hormone level testing is a useful screening test in women with high risk of diminished ovarian reserve and in women undergoing IVF or test tube baby treatment. But it has limited benefits for someone at low risk of diminished ovarian reserve. This hor mone is measured through a blood test.The third test is the antral follicle count, which tallies visible ovarian follicles count, where the clinicians visibly count the ovarian follicles by performing a pelvic ultrasound (scan). This is the most significant predictor of poor response to ovarian stimulation, among other tests.
The primary goal of ovarian reserve testing is to identify women at risk of decreased or diminished ovarian reserve, with a secondary goal of individualising treatment strategies for each woman. Although these tests may predict ovarian response to infertility treatment, they do not reliably predict failure to conceive.
For appointment and further queries contact, Dr Radhika Reddy Pingili, MBBS, MD, MRCOG, DFSRH, CCT (UK), Consultant ART and Infertility Specialist, Surya Fertility Centre For more information log onto http:www.suryafertilitycentre.in or write in to firstname.lastname@example.org For details, call: 040-2360873488850131000102